Azerbaijan National Academy of Sciences

The State Intellectual Property Office of the PRC issued the first patent for a coronavirus vaccine.

The patent was received by the Academy of Military Medical Sciences of the People's Liberation Army and CanSino Biologics, which developed a recombinant vaccine against COVID-19 (based on the adenoviral vector) Ad5-nCoV.

In June, the vaccine received a special one-year license for military use. In March, the drug became the first in China to be approved for clinical trials.

Gazeta.ru